Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2026 ,inter alia, to consider and approve the issuance of listed, rated, unsecured, redeemable, non-convertible debentures

Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel. : (91-22) 4324 4324 Fax : (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 07 October 2026 National Stock Exchange of India Limited BSE Limited NSE Code: SUNPHARMA Stock Code: 524715 Intimation under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Board Meeting and Connected matters This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 12 October 2026, inter alia, to consider and approve the issuance of listed, rated, unsecured, redeemable non-convertible debentures (“NCDs”), in one or more tranches, on a private placement basis, for an aggregate amount not exceeding INR 15,000 Crore (Indian Rupees Fifteen Thousand Crore only), and to consider matters incidental and connected thereto. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA. Reaching People. Touching Lives.